Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophreniaSophie Hackinger, Eleftheria Zeggini, George Dedoussis et al.|Translational Psychiatry|2018Cited by 95
Schizophrenia and type 2 diabetes mellitusVasiliki Mamakou, V.P. Kontaxakis, Anastasia Thanopoulou et al.|Psychiatriki|2018Cited by 73
Evaluating the glucose raising effect of established loci via a genetic risk scoreEirini Marouli, Stavroula Kanoni, Vasiliki Mamakou et al.|PLoS ONE|2017Cited by 6
Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP studyVasiliki Mamakou, Eleftheria Zeggini, Sophie Hackinger et al.|BMC Psychiatry|2018Cited by 5
Author Correction: The power of genetic diversity in genome-wide association studies of lipidsJirong Long, Derek Klarin, Ketian Yu et al.|RePEc: Research Papers in Economics|2024Cited by 0